메뉴 건너뛰기




Volumn 2, Issue 3-4, 2002, Pages 228-251

Acute and prophylactic effects of anticonvulsants in bipolar depression

Author keywords

Anticonvulsants; Bipolar disorder; Carbamazepine; Depression; Gabapentin; Lamotrigine; Lithium; Valproate

Indexed keywords

ACETAZOLAMIDE; ALPRAZOLAM; AMFEBUTAMONE; AMLODIPINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; FLUNITRAZAPINE; GABAPENTIN; IMIPRAMINE; ISRADIPINE; LAMOTRIGINE; LITHIUM CARBONATE; LORAZEPAM; NIMODIPINE; OMEGA 3 FATTY ACID; OXCARBAZEPINE; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL; ZONISAMIDE;

EID: 0036891477     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(02)00047-6     Document Type: Review
Times cited : (19)

References (240)
  • 1
    • 0032993716 scopus 로고    scopus 로고
    • Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders
    • Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999;60(Suppl 2):77-84.
    • (1999) J. Clin. Psychiatry , vol.60 , Issue.SUPPL. 2 , pp. 77-84
    • Baldessarini, R.J.1    Tondo, L.2    Hennen, J.3
  • 3
    • 0026726290 scopus 로고
    • The effect of longterm lithium treatment on the mortality of patients with manicdepressive and schizoaffective illness
    • Muller-Oerlinghausen B, Ahrens B, Grof E, et al. The effect of longterm lithium treatment on the mortality of patients with manicdepressive and schizoaffective illness. Acta Psychiatr Scand 1992;86:218-222.
    • (1992) Acta Psychiatr. Scand. , vol.86 , pp. 218-222
    • Muller-Oerlinghausen, B.1    Ahrens, B.2    Grof, E.3
  • 4
    • 0026731112 scopus 로고
    • Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication
    • Muller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992;25:261-269.
    • (1992) J. Affect. Disord. , vol.25 , pp. 261-269
    • Muller-Oerlinghausen, B.1    Muser-Causemann, B.2    Volk, J.3
  • 5
    • 0028893706 scopus 로고
    • Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis
    • Ahrens B, Muller-Oerlinghausen B, Schou M, et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995;33:67-75.
    • (1995) J. Affect. Disord. , vol.33 , pp. 67-75
    • Ahrens, B.1    Muller-Oerlinghausen, B.2    Schou, M.3
  • 7
    • 0033587742 scopus 로고    scopus 로고
    • Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons
    • Chalecka-Franaszek E, Chuang DM. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999;96:8745-8750.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 8745-8750
    • Chalecka-Franaszek, E.1    Chuang, D.M.2
  • 8
    • 0031870871 scopus 로고    scopus 로고
    • Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine
    • Nonaka S, Katsube N, Chuang DM. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998;286:539-547.
    • (1998) J. Pharmacol. Exp. Ther. , vol.286 , pp. 539-547
    • Nonaka, S.1    Katsube, N.2    Chuang, D.M.3
  • 9
    • 0032478088 scopus 로고    scopus 로고
    • Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx
    • Nonaka S, Hough CJ, Chuang DM. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998;95:2642-2647.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 2642-2647
    • Nonaka, S.1    Hough, C.J.2    Chuang, D.M.3
  • 10
    • 0036116367 scopus 로고    scopus 로고
    • Neuroprotective effects of lithium in cultured cells and animal models of diseases
    • Chuang DM, Chen RW, Chalecka-Franaszek E, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002;4:129-136.
    • (2002) Bipolar. Disord. , vol.4 , pp. 129-136
    • Chuang, D.M.1    Chen, R.W.2    Chalecka-Franaszek, E.3
  • 11
    • 0033525538 scopus 로고    scopus 로고
    • Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity
    • Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999;274:6039-6042.
    • (1999) J. Biol. Chem. , vol.274 , pp. 6039-6042
    • Chen, R.W.1    Chuang, D.M.2
  • 12
    • 0034795827 scopus 로고    scopus 로고
    • Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain
    • Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001;158:100-106.
    • (2001) Psychopharmacology (Berl) , vol.158 , pp. 100-106
    • Fukumoto, T.1    Morinobu, S.2    Okamoto, Y.3    Kagaya, A.4    Yamawaki, S.5
  • 13
    • 0032557889 scopus 로고    scopus 로고
    • Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
    • Nonaka S, Chuang DM. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998;9:2081-2084.
    • (1998) Neuroreport , vol.9 , pp. 2081-2084
    • Nonaka, S.1    Chuang, D.M.2
  • 14
    • 0035960005 scopus 로고    scopus 로고
    • Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease
    • Wei H, Qin Z, Senatorov VV, et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 2001;106:603-612.
    • (2001) Neuroscience , vol.106 , pp. 603-612
    • Wei, H.1    Qin, Z.2    Senatorov, V.V.3
  • 15
    • 18744435263 scopus 로고    scopus 로고
    • Lithium increases Nacetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects?
    • Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases Nacetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000;48:1-8.
    • (2000) Biol. Psychiatry , vol.48 , pp. 1-8
    • Moore, G.J.1    Bebchuk, J.M.2    Hasanat, K.3
  • 17
    • 0035878181 scopus 로고    scopus 로고
    • Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium
    • Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001;55:651-659.
    • (2001) Brain Res. Bull. , vol.55 , pp. 651-659
    • Knable, M.B.1    Torrey, E.F.2    Webster, M.J.3    Bartko, J.J.4
  • 18
    • 0015751682 scopus 로고
    • Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report
    • Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr Neurol Jpn 1973;27:283-297.
    • (1973) Folia Psychiatr. Neurol. Jpn. , vol.27 , pp. 283-297
    • Okuma, T.1    Kishimoto, A.2    Inoue, K.3    Matsumoto, H.4    Ogura, A.5
  • 19
    • 0011571986 scopus 로고
    • Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic-depressive psychosis
    • Okuma T, Kishimoto A, Inoue K. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic-depressive psychosis. Seishin Igaku 1975;17:617-630.
    • (1975) Seishin Igaku , vol.17 , pp. 617-630
    • Okuma, T.1    Kishimoto, A.2    Inoue, K.3
  • 20
    • 0020082544 scopus 로고
    • Carbamazepine treatment of selected affectively disordered inpatients
    • Folks DG, King LD, Dowdy SB, et al. Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiatry 1982;139:115-117.
    • (1982) Am. J. Psychiatry , vol.139 , pp. 115-117
    • Folks, D.G.1    King, L.D.2    Dowdy, S.B.3
  • 21
    • 0021367113 scopus 로고
    • The treatment of chronic depression. An illustrative case
    • Barker WA, Eccleston D. The treatment of chronic depression. An illustrative case. Br J Psychiatry 1984;144:317-319.
    • (1984) Br. J. Psychiatry , vol.144 , pp. 317-319
    • Barker, W.A.1    Eccleston, D.2
  • 22
    • 0001204978 scopus 로고
    • Carbamazepine in affective disorders
    • Emrich HM, Okuma T, Muller AA, editors. Amsterdam: Excerpta Medica
    • Sethi BB, Tiwari SC. Carbamazepine in affective disorders. In: Emrich HM, Okuma T, Muller AA, editors. Anticonvulsants in affective disorders, Amsterdam: Excerpta Medica, 1984. pp. 167-176.
    • (1984) Anticonvulsants in Affective Disorders , pp. 167-176
    • Sethi, B.B.1    Tiwari, S.C.2
  • 23
    • 0021869192 scopus 로고
    • Carbamazepine in manic depressive psychosis
    • Arap MH. Carbamazepine in manic depressive psychosis. East Afr Med J 1985;62:172-174.
    • (1985) East Afr. Med. J. , vol.62 , pp. 172-174
    • Arap, M.H.1
  • 24
    • 0022401743 scopus 로고
    • Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: Case report
    • Nurnberg HG, Finkel JA. Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: case report. J Clin Psychiatry 1985;46:487-488.
    • (1985) J. Clin. Psychiatry , vol.46 , pp. 487-488
    • Nurnberg, H.G.1    Finkel, J.A.2
  • 25
    • 0022408703 scopus 로고
    • Efficacy of carbamazepine as an antidepressant in chronic resistant depressives
    • Prasad AJ. Efficacy of carbamazepine as an antidepressant in chronic resistant depressives. J Indian Med Assoc 1985;83:235-237.
    • (1985) J. Indian Med. Assoc. , vol.83 , pp. 235-237
    • Prasad, A.J.1
  • 27
    • 0025838234 scopus 로고
    • Carbamazepine for treatment-resistant melancholia
    • Cullen M, Mitchell P, Brodaty H, et al. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 1991;52:472-476.
    • (1991) J. Clin. Psychiatry , vol.52 , pp. 472-476
    • Cullen, M.1    Mitchell, P.2    Brodaty, H.3
  • 29
    • 0030297725 scopus 로고    scopus 로고
    • Treatment of bipolar depression with carbamazepine: Results of an open study
    • Dilsaver SC, Swann SC, Chen YW, et al. Treatment of bipolar depression with carbamazepine: results of an open study. Biol Psychiatry 1996;40:935-937.
    • (1996) Biol. Psychiatry , vol.40 , pp. 935-937
    • Dilsaver, S.C.1    Swann, S.C.2    Chen, Y.W.3
  • 31
    • 0001849970 scopus 로고
    • Comparative studies of the effect of carbamazepine and trimipramine in depression
    • Emrich HM, Okuma T, Muller AA, editors. Amsterdam: Excerpta Medica
    • Neumann J, Seidel K, Wunderlich H-P. Comparative studies of the effect of carbamazepine and trimipramine in depression. In: Emrich HM, Okuma T, Muller AA, editors. Anticonvulsants in affective disorders, Amsterdam: Excerpta Medica, 1984. pp. 160-166.
    • (1984) Anticonvulsants in Affective Disorders , pp. 160-166
    • Neumann, J.1    Seidel, K.2    Wunderlich, H.-P.3
  • 32
  • 35
    • 0025183101 scopus 로고
    • Anticonvulsants in affective disorders
    • Small JG. Anticonvulsants in affective disorders. Psychopharmacol Bull 1990;26:25-36.
    • (1990) Psychopharmacol. Bull. , vol.26 , pp. 25-36
    • Small, J.G.1
  • 37
    • 0036154796 scopus 로고    scopus 로고
    • New designs for studies of the prophylaxis of bipolar disorder
    • Post RM, Keck JP, Rush AJ. New designs for studies of the prophylaxis of bipolar disorder. J Clin Psychopharmacol 2002;22:1-3.
    • (2002) J. Clin. Psychopharmacol. , vol.22 , pp. 1-3
    • Post, R.M.1    Keck, J.P.2    Rush, A.J.3
  • 38
    • 0011694318 scopus 로고    scopus 로고
    • Unique design issues in clinical trials of patients with bipolar affective disorder
    • in press
    • Post RM, Luckenbaugh D. Unique design issues in clinical trials of patients with bipolar affective disorder. J Psychiatr Res 2002 in press.
    • (2002) J. Psychiatr. Res.
    • Post, R.M.1    Luckenbaugh, D.2
  • 39
    • 0021690779 scopus 로고
    • Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications
    • Roy-Byrne PP, Joffe RT, Uhde TW, Post RM. Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications. Arch Gen Psychiatry 1984;41:1150-1153.
    • (1984) Arch. Gen. Psychiatry , vol.41 , pp. 1150-1153
    • Roy-Byrne, P.P.1    Joffe, R.T.2    Uhde, T.W.3    Post, R.M.4
  • 40
    • 0032703836 scopus 로고    scopus 로고
    • Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders
    • Ketter TA, Kimbrell TA, George MS, et al. Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. Biol Psychiatry 1999;46:1364-1374.
    • (1999) Biol. Psychiatry , vol.46 , pp. 1364-1374
    • Ketter, T.A.1    Kimbrell, T.A.2    George, M.S.3
  • 41
  • 42
    • 0031690746 scopus 로고    scopus 로고
    • Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness
    • Pazzaglia PJ, Post RM, Ketter TA, et al. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol 1998;18:404-413.
    • (1998) J. Clin. Psychopharmacol. , vol.18 , pp. 404-413
    • Pazzaglia, P.J.1    Post, R.M.2    Ketter, T.A.3
  • 43
    • 0018119821 scopus 로고
    • Therapeutic effects of carbamazepine in affective illness: Preliminary report
    • Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: preliminary report. Commun Psychopharmacol 1978;2:159-175.
    • (1978) Commun. Psychopharmacol. , vol.2 , pp. 159-175
    • Ballenger, J.C.1    Post, R.M.2
  • 45
    • 0019460596 scopus 로고
    • A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness
    • Okuma T, Inanaga K, Otsuki S, et al. A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 1981;73:95-96.
    • (1981) Psychopharmacology , vol.73 , pp. 95-96
    • Okuma, T.1    Inanaga, K.2    Otsuki, S.3
  • 46
    • 0022349748 scopus 로고
    • Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate)
    • Svestka J, Nahunek K, Ceskova E, Korbicka J. Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate). Activ Nerv Sup 1985;27:261-262.
    • (1985) Activ. Nerv. Sup. , vol.27 , pp. 261-262
    • Svestka, J.1    Nahunek, K.2    Ceskova, E.3    Korbicka, J.4
  • 47
    • 0003043296 scopus 로고
    • Antimanic and prophylactic effects of carbamazepine in affective disorders
    • Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM, editors. New York: Elsevier
    • Kishimoto A, Okuma T. Antimanic and prophylactic effects of carbamazepine in affective disorders. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM, editors. Biological psychiatry 1985, New York: Elsevier, 1986. pp. 883-885.
    • (1986) Biological Psychiatry 1985 , pp. 883-885
    • Kishimoto, A.1    Okuma, T.2
  • 48
    • 0023029861 scopus 로고
    • Long-term randomized clinical trial on oxcarbazepine vs. lithium in bipolar and schizoaffective disorders: Preliminary results
    • Cabrera JF, Muhlbauer HD, Schley J, Stoll KD, Muller-Oerlinghausen B. Long-term randomized clinical trial on oxcarbazepine vs. lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 1986;19:282-283.
    • (1986) Pharmacopsychiatry , vol.19 , pp. 282-283
    • Cabrera, J.F.1    Muhlbauer, H.D.2    Schley, J.3    Stoll, K.D.4    Muller-Oerlinghausen, B.5
  • 49
    • 0022982141 scopus 로고
    • The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients
    • Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986;47:490-494.
    • (1986) J. Clin. Psychiatry , vol.47 , pp. 490-494
    • Placidi, G.F.1    Lenzi, A.2    Lazzerini, F.3    Cassano, G.B.4    Akiskal, H.S.5
  • 51
    • 0023733184 scopus 로고
    • Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness
    • Elphick M, Lyons F, Cowen PJ. Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. J Psychopharmacol 1988;2:1-4.
    • (1988) J. Psychopharmacol. , vol.2 , pp. 1-4
    • Elphick, M.1    Lyons, F.2    Cowen, P.J.3
  • 52
    • 0023790128 scopus 로고
    • Carbamazepine vs. lithium in the treatment and prophylaxis of mania
    • Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988;153:198-204.
    • (1988) Br. J. Psychiatry , vol.153 , pp. 198-204
    • Lusznat, R.M.1    Murphy, D.P.2    Nunn, C.M.3
  • 53
    • 0025215111 scopus 로고
    • Carbamazepine vs. lithium. Application in the prophylaxis of recurrent affective and schizoaffective psychoses
    • Bellaire W, Demisch K, Stoll K-D. Carbamazepine vs. lithium. Application in the prophylaxis of recurrent affective and schizoaffective psychoses. Munch Med Wschr 1990;132:S82-S86.
    • (1990) Munch. Med. Wschr. , vol.132
    • Bellaire, W.1    Demisch, K.2    Stoll, K.-D.3
  • 54
    • 0025732916 scopus 로고
    • Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder
    • Di Costanzo E, Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 1991;83:456-459.
    • (1991) Acta Psychiatr. Scand. , vol.83 , pp. 456-459
    • Di Costanzo, E.1    Schifano, F.2
  • 55
    • 0025922939 scopus 로고
    • [Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses]
    • Mosolov SN. [Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses]. Zh Nevropatol Psikhiatr 1991;91:78-83.
    • (1991) Zh Nevropatol Psikhiatr , vol.91 , pp. 78-83
    • Mosolov, S.N.1
  • 56
    • 0026503621 scopus 로고
    • Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder
    • Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992;85:114-118.
    • (1992) Acta Psychiatr. Scand. , vol.85 , pp. 114-118
    • Coxhead, N.1    Silverstone, T.2    Cookson, J.3
  • 57
  • 58
    • 0000624443 scopus 로고    scopus 로고
    • Carbamazepine versus lithium in the prophylaxis of bipolar affective disorders: A randomised, doubleblind 1-year study in 168 patients
    • Wolf C, Berky M, Kovacs G. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorders: a randomised, doubleblind 1-year study in 168 patients. Eur Neuropsychopharmacol 1997;7(Suppl 2):S176.
    • (1997) Eur. Neuropsychopharmacol. , vol.7 , Issue.SUPPL. 2
    • Wolf, C.1    Berky, M.2    Kovacs, G.3
  • 59
    • 0033303189 scopus 로고    scopus 로고
    • The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder
    • Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 1999;14:277-281.
    • (1999) Int. Clin. Psychopharmacol. , vol.14 , pp. 277-281
    • Greil, W.1    Kleindienst, N.2
  • 60
    • 0033303289 scopus 로고    scopus 로고
    • Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified
    • Greil W, Kleindienst N. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 1999;14:283-285.
    • (1999) Int. Clin. Psychopharmacol. , vol.14 , pp. 283-285
    • Greil, W.1    Kleindienst, N.2
  • 62
    • 0033652406 scopus 로고    scopus 로고
    • Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: Results of the MAP study
    • Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42(Suppl 1):2-10.
    • (2000) Neuropsychobiology , vol.42 , Issue.SUPPL. 1 , pp. 2-10
    • Kleindienst, N.1    Greil, W.2
  • 63
    • 4243990422 scopus 로고    scopus 로고
    • Anticonvulsants in bipolar illness with alcohol comorbidity
    • American Psychiatric Association Annual Meeting, Chicago, IL, May 13-18
    • Frye MA, Denicoff KD, Smith-Jackson E, Vanderham E, Leverich GS, Post RM. Anticonvulsants in bipolar illness with alcohol comorbidity. American Psychiatric Association Annual Meeting, Chicago, IL, May 13-18, 2000.
    • (2000)
    • Frye, M.A.1    Denicoff, K.D.2    Smith-Jackson, E.3    Vanderham, E.4    Leverich, G.S.5    Post, R.M.6
  • 65
    • 0020064463 scopus 로고
    • Treatment of acute alcohol withdrawal syndrome with carbamazepine: A doubleblind comparison with tiapride
    • Agricola R, Mazzarino M, Urani R, Gallo V, Grossi E. Treatment of acute alcohol withdrawal syndrome with carbamazepine: a doubleblind comparison with tiapride. J Int Med Res 1982;10:160-165.
    • (1982) J. Int. Med. Res. , vol.10 , pp. 160-165
    • Agricola, R.1    Mazzarino, M.2    Urani, R.3    Gallo, V.4    Grossi, E.5
  • 66
    • 0021262671 scopus 로고
    • Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses
    • Ballenger JC, Post RM. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull 1984;20:572-584.
    • (1984) Psychopharmacol. Bull. , vol.20 , pp. 572-584
    • Ballenger, J.C.1    Post, R.M.2
  • 67
    • 0028281080 scopus 로고
    • Efficacy of divalproex vs. lithium and placebo in the treatment of mania
    • The Depakote Mania Study Group
    • Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J Am Med Assoc 1994;271:918-924.
    • (1994) J. Am. Med. Assoc. , vol.271 , pp. 918-924
    • Bowden, C.L.1    Brugger, A.M.2    Swann, A.C.3
  • 69
  • 72
    • 0002299950 scopus 로고
    • Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide)
    • Emrich HM, Okuma T, Muller AA, editors. Amsterdam: Excerpta Medica
    • Lambert PA. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Muller AA, editors. Anticonvulsants in affective disorders, Amsterdam: Excerpta Medica, 1984. pp. 33-44.
    • (1984) Anticonvulsants in Affective Disorders , pp. 33-44
    • Lambert, P.A.1
  • 73
    • 0023605089 scopus 로고
    • [Use of valpromide in psychiatric therapeutics]
    • Lambert PA, Venaud G. [Use of valpromide in psychiatric therapeutics]. Encephale 1987;13:367-373.
    • (1987) Encephale , vol.13 , pp. 367-373
    • Lambert, P.A.1    Venaud, G.2
  • 76
    • 0001966149 scopus 로고
    • Comparative study of valpromide vs. lithium as prophylactic treatments in affective disorders
    • Lambert PA, Venaud G. Comparative study of valpromide vs. lithium as prophylactic treatments in affective disorders. Nerv J Psychiatr 1995:1-9.
    • (1995) Nerv. J. Psychiatr. , pp. 1-9
    • Lambert, P.A.1    Venaud, G.2
  • 77
    • 0034013393 scopus 로고    scopus 로고
    • A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
    • Divalproex Maintenance Study Group
    • Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-489.
    • (2000) Arch. Gen. Psychiatry , vol.57 , pp. 481-489
    • Bowden, C.L.1    Calabrese, J.R.2    McElroy, S.L.3
  • 80
    • 0031012799 scopus 로고    scopus 로고
    • Depression during mania. Treatment response to lithium or divalproex
    • Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997;54:37-42.
    • (1997) Arch. Gen. Psychiatry , vol.54 , pp. 37-42
    • Swann, A.C.1    Bowden, C.L.2    Morris, D.3
  • 84
    • 0028323487 scopus 로고
    • Panic disorder: Treatment with valproate
    • Woodman CL, Noyes RJ. Panic disorder: treatment with valproate. J Clin Psychiatry 1994;55:134-136.
    • (1994) J. Clin. Psychiatry , vol.55 , pp. 134-136
    • Woodman, C.L.1    Noyes, R.J.2
  • 85
    • 0026742320 scopus 로고
    • GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate
    • Motohashi N. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:571-579.
    • (1992) Prog. Neuropsychopharmacol. Biol. Psychiatry , vol.16 , pp. 571-579
    • Motohashi, N.1
  • 86
    • 0019400439 scopus 로고
    • On the possible role of GABA in mania. Therapeutic efficacy of sodium valproate
    • Costa E, editor. New York: Raven
    • Emrich HM, Von Zerssen D, Kissling W, Moller H-J. On the possible role of GABA in mania. Therapeutic efficacy of sodium valproate. In: Costa E, editor. GABA and benzodiazepine receptors, New York: Raven, 1981. pp. 287-296.
    • (1981) GABA and Benzodiazepine Receptors , pp. 287-296
    • Emrich, H.M.1    Von Zerssen, D.2    Kissling, W.3    Moller, H.-J.4
  • 87
    • 0002710089 scopus 로고    scopus 로고
    • Lithium, carbamazepine, and valproate in affective illness: Biochemical and neurobiological mechanisms
    • Manji H, Bowden CL, Belmaker RH, editors. Washington, DC: American Psychiatric Press
    • Post RM, Weiss SRB, Clark M, Chuang DM, Hough C, Li H. Lithium, carbamazepine, and valproate in affective illness: biochemical and neurobiological mechanisms. In: Manji H, Bowden CL, Belmaker RH, editors. Bipolar medications: mechanisms of action, Washington, DC: American Psychiatric Press, 2000. pp. 219-248.
    • (2000) Bipolar Medications: Mechanisms of Action , pp. 219-248
    • Post, R.M.1    Weiss, S.R.B.2    Clark, M.3    Chuang, D.M.4    Hough, C.5    Li, H.6
  • 88
    • 0033697737 scopus 로고    scopus 로고
    • A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
    • Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-614.
    • (2000) J. Clin. Psychopharmacol. , vol.20 , pp. 607-614
    • Frye, M.A.1    Ketter, T.A.2    Kimbrell, T.A.3
  • 89
    • 0034278763 scopus 로고    scopus 로고
    • Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy
    • Gabapentin Bipolar Disorder Study Group
    • Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000;2:249-255.
    • (2000) Bipolar. Disord. , vol.2 , pp. 249-255
    • Pande, A.C.1    Crockatt, J.G.2    Janney, C.A.3    Werth, J.L.4    Tsaroucha, G.5
  • 91
    • 0033004838 scopus 로고    scopus 로고
    • A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
    • Lamictal 602 Study Group
    • Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60:79-88.
    • (1999) J. Clin. Psychiatry , vol.60 , pp. 79-88
    • Calabrese, J.R.1    Bowden, C.L.2    Sachs, G.S.3    Ascher, J.A.4    Monaghan, E.5    Rudd, G.D.6
  • 93
    • 0342301745 scopus 로고    scopus 로고
    • Lamotrigine-associated rash: Risk/benefit considerations in adults and children
    • Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999;40:985-991.
    • (1999) Epilepsia , vol.40 , pp. 985-991
    • Guberman, A.H.1    Besag, F.M.2    Brodie, M.J.3
  • 94
    • 0031555277 scopus 로고    scopus 로고
    • Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP
    • Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997;73:159-171.
    • (1997) Psychiatry Res. , vol.73 , pp. 159-171
    • Spearing, M.K.1    Post, R.M.2    Leverich, G.S.3    Brandt, D.4    Nolen, W.5
  • 95
    • 0036468685 scopus 로고    scopus 로고
    • Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders
    • Obrocea GV, Dunn RM, Frye MA, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002;51:253-260.
    • (2002) Biol. Psychiatry , vol.51 , pp. 253-260
    • Obrocea, G.V.1    Dunn, R.M.2    Frye, M.A.3
  • 96
    • 0034005897 scopus 로고    scopus 로고
    • Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: Cross-tolerance to carbamazepine but not valproate or diazepam
    • Krupp E, Heynen T, Li XL, Post RM, Weiss SR. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam. Exp Neurol 2000;162:278-289.
    • (2000) Exp. Neurol. , vol.162 , pp. 278-289
    • Krupp, E.1    Heynen, T.2    Li, X.L.3    Post, R.M.4    Weiss, S.R.5
  • 97
    • 0030454477 scopus 로고    scopus 로고
    • Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
    • Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport 1996;7:3037-3040.
    • (1996) Neuroreport , vol.7 , pp. 3037-3040
    • Wang, S.J.1    Huang, C.C.2    Hsu, K.S.3    Tsai, J.J.4    Gean, P.W.5
  • 99
    • 0033051765 scopus 로고    scopus 로고
    • Lamictal (lamotrigine) monotherapy for typical absence seizures in children
    • Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-979.
    • (1999) Epilepsia , vol.40 , pp. 973-979
    • Frank, L.M.1    Enlow, T.2    Holmes, G.L.3
  • 101
    • 0036501615 scopus 로고    scopus 로고
    • Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression
    • Dunn RT, Kimbrell TA, Ketter TA, et al. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 2002;51:387-399.
    • (2002) Biol. Psychiatry , vol.51 , pp. 387-399
    • Dunn, R.T.1    Kimbrell, T.A.2    Ketter, T.A.3
  • 102
    • 0022879349 scopus 로고
    • Preliminary study of carbamazepine in post-traumatic stress disorder
    • Lipper S, Davidson JRT, Grady TA, et al. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 1986;27:849-854.
    • (1986) Psychosomatics , vol.27 , pp. 849-854
    • Lipper, S.1    Davidson, J.R.T.2    Grady, T.A.3
  • 103
    • 0024444903 scopus 로고
    • Sleep disorders and depression with atypical features: Response to valproate
    • Pies R, Adler DA, Ehrenberg BL. Sleep disorders and depression with atypical features: response to valproate. J Clin Psychopharmacol 1989;9:352-357.
    • (1989) J. Clin. Psychopharmacol. , vol.9 , pp. 352-357
    • Pies, R.1    Adler, D.A.2    Ehrenberg, B.L.3
  • 104
    • 0026558528 scopus 로고
    • Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes
    • Keck PEJ, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992;12:36S-41S.
    • (1992) J. Clin. Psychopharmacol. , vol.12
    • Keck, P.E.J.1    McElroy, S.L.2    Friedman, L.M.3
  • 106
    • 0029837862 scopus 로고    scopus 로고
    • Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder
    • Walden J, Hesslinger B, Van Calker D, Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996;29:193-195.
    • (1996) Pharmacopsychiatry , vol.29 , pp. 193-195
    • Walden, J.1    Hesslinger, B.2    Van Calker, D.3    Berger, M.4
  • 107
    • 0011633643 scopus 로고    scopus 로고
    • Lamotrigine in bipolar disorder: Preliminary data
    • Syllabus and proceedings summary of the 150th American Psychiatric Association Meeting, May 17-22
    • Calabrese JR, Bowden CL, McElroy SL, Cookson J, Anderson J, Rhodes LJ, et al. Lamotrigine in bipolar disorder: preliminary data. Syllabus and proceedings summary of the 150th American Psychiatric Association Meeting, May 17-22, 1997.
    • (1997)
    • Calabrese, J.R.1    Bowden, C.L.2    McElroy, S.L.3    Cookson, J.4    Anderson, J.5    Rhodes, L.J.6
  • 109
    • 0030762529 scopus 로고    scopus 로고
    • Lamotrigine treatment of refractory bipolar disorder
    • Fogelson DL, Sternbach H. Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry 1997;58:271-273.
    • (1997) J. Clin. Psychiatry , vol.58 , pp. 271-273
    • Fogelson, D.L.1    Sternbach, H.2
  • 111
    • 0030910672 scopus 로고    scopus 로고
    • The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness
    • Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-189.
    • (1997) J. Clin. Psychopharmacol. , vol.17 , pp. 185-189
    • Sporn, J.1    Sachs, G.2
  • 112
    • 0030855447 scopus 로고    scopus 로고
    • Lamotrigine treatment of rapid cycling bipolar disorder
    • [letter; comment]
    • Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cycling bipolar disorder [letter; comment]. Am J Psychiatry 1997;154:1171-1172.
    • (1997) Am. J. Psychiatry , vol.154 , pp. 1171-1172
    • Kusumakar, V.1    Yatham, L.N.2
  • 113
    • 0030778964 scopus 로고    scopus 로고
    • An open study of lamotrigine in refractory bipolar depression
    • Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-148.
    • (1997) Psychiatry Res. , vol.72 , pp. 145-148
    • Kusumakar, V.1    Yatham, L.N.2
  • 114
    • 0003042752 scopus 로고    scopus 로고
    • Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents
    • Mandoki M. Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents. Biol Psychiatry 1997;41:93S-94S.
    • (1997) Biol. Psychiatry , vol.41
    • Mandoki, M.1
  • 115
    • 0031952012 scopus 로고    scopus 로고
    • Lamotrigine in the treatment of resistant bipolar disorder
    • Kotler M, Matar MA. Lamotrigine in the treatment of resistant bipolar disorder. Clin Neuropharmacol 1998;21:65-67.
    • (1998) Clin. Neuropharmacol. , vol.21 , pp. 65-67
    • Kotler, M.1    Matar, M.A.2
  • 117
    • 0033561206 scopus 로고    scopus 로고
    • The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder
    • Bowden CL, Calabrese JR, McElroy SL, et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry 1999;45:953-958.
    • (1999) Biol. Psychiatry , vol.45 , pp. 953-958
    • Bowden, C.L.1    Calabrese, J.R.2    McElroy, S.L.3
  • 118
    • 0032913616 scopus 로고    scopus 로고
    • Lamotrigine for the treatment of bipolar disorder: A clinical case series
    • Suppes T, Brown ES, McElroy SL, et al. Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disord 1999;53:95-98.
    • (1999) J. Affect. Disord. , vol.53 , pp. 95-98
    • Suppes, T.1    Brown, E.S.2    McElroy, S.L.3
  • 119
    • 0034569460 scopus 로고    scopus 로고
    • An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization
    • Walden J, Schaerer L, Schloesser S, Grunze H. An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. Bipolar Disord 2000;2:336-339.
    • (2000) Bipolar. Disord. , vol.2 , pp. 336-339
    • Walden, J.1    Schaerer, L.2    Schloesser, S.3    Grunze, H.4
  • 120
    • 0033815917 scopus 로고    scopus 로고
    • Use of lamotrigine in a patient with bipolar disorder and psychiatric comorbidity
    • Ballasiotes AA, Skaer TL. Use of lamotrigine in a patient with bipolar disorder and psychiatric comorbidity. Clin Ther 2000;22:1146-1148.
    • (2000) Clin. Ther. , vol.22 , pp. 1146-1148
    • Ballasiotes, A.A.1    Skaer, T.L.2
  • 121
    • 0034090550 scopus 로고    scopus 로고
    • Lamotrigine compared with lithium in mania: A double-blind randomized controlled trial
    • Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000;12:5-10.
    • (2000) Ann. Clin. Psychiatry , vol.12 , pp. 5-10
    • Ichim, L.1    Berk, M.2    Brook, S.3
  • 122
    • 0033696203 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder
    • Lamictal 614 Study Group
    • Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-850.
    • (2000) J. Clin. Psychiatry , vol.61 , pp. 841-850
    • Calabrese, J.R.1    Suppes, T.2    Bowden, C.L.3
  • 123
    • 0037385145 scopus 로고    scopus 로고
    • A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder
    • in press
    • Bowden CL, Calabrese JR, Sachs GS, Yatham LN, Ashgar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2002 in press.
    • (2002) Arch. Gen. Psychiatry
    • Bowden, C.L.1    Calabrese, J.R.2    Sachs, G.S.3    Yatham, L.N.4    Ashgar, S.A.5    Hompland, M.6
  • 124
    • 0002486910 scopus 로고    scopus 로고
    • Summary and meta-analysis of two large placebo-controlled 18-month maintenance trials of lamotrigine and lithium treatment in bipolar I disorder
    • Calabrese JR, Soegaard J, Hompland M, Mehtonen OP, Ruetsch G, Paska W. Summary and meta-analysis of two large placebo-controlled 18-month maintenance trials of lamotrigine and lithium treatment in bipolar I disorder. Int J Neuropsychopharmacol 2002;5:S58.
    • (2002) Int. J. Neuropsychopharmacol. , vol.5
    • Calabrese, J.R.1    Soegaard, J.2    Hompland, M.3    Mehtonen, O.P.4    Ruetsch, G.5    Paska, W.6
  • 125
    • 0002536908 scopus 로고    scopus 로고
    • Clinical presentation of bipolar disorders responsive to lithium or lamotrigine
    • Alda M, Passmore MJ, Garnham J, et al. Clinical presentation of bipolar disorders responsive to lithium or lamotrigine. Int J Neuropsychopharmacol 2002;5:S58.
    • (2002) Int. J. Neuropsychopharmacol. , vol.5
    • Alda, M.1    Passmore, M.J.2    Garnham, J.3
  • 126
    • 0030978468 scopus 로고    scopus 로고
    • Gabapentin for treatment of bipolar and schizoaffective disorders
    • Bennett J, Goldman WT, Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders. J Clin Psychopharmacol 1997;17:141-142.
    • (1997) J. Clin. Psychopharmacol. , vol.17 , pp. 141-142
    • Bennett, J.1    Goldman, W.T.2    Suppes, T.3
  • 127
    • 0000220945 scopus 로고    scopus 로고
    • Gabapentin: An effective therapy for patients with bipolar affective disorder
    • Marcotte DB, Fogleman L, Wolfe N, Nemire R. Gabapentin: an effective therapy for patients with bipolar affective disorder. APA New Res Prog Abstr 1997;NR261:138.
    • (1997) APA New Res. Prog. Abstr. , vol.261 NR , pp. 138
    • Marcotte, D.B.1    Fogleman, L.2    Wolfe, N.3    Nemire, R.4
  • 130
    • 0031029401 scopus 로고    scopus 로고
    • Gabapentin in the treatment of bipolar disorder
    • [letter]
    • Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder [letter]. Am J Psychiatry 1997;154:291-292.
    • (1997) Am. J. Psychiatry , vol.154 , pp. 291-292
    • Schaffer, C.B.1    Schaffer, L.C.2
  • 133
    • 0031980513 scopus 로고    scopus 로고
    • Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
    • Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998;49:229-233.
    • (1998) J. Affect. Disord. , vol.49 , pp. 229-233
    • Knoll, J.1    Stegman, K.2    Suppes, T.3
  • 136
    • 0033188208 scopus 로고    scopus 로고
    • Gabapentin in the acute treatment of refractory bipolar disorder
    • Altshuler LL, Keck Jr PE, McElroy SL, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1999;1:61-65.
    • (1999) Bipolar. Disord. , vol.1 , pp. 61-65
    • Altshuler, L.L.1    Keck P.E., Jr.2    McElroy, S.L.3
  • 137
    • 0032910702 scopus 로고    scopus 로고
    • Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: Results of an open-label study
    • Cabras PL, Hardoy MJ, Hardoy MC, Carta MG. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study. J Clin Psychiatry 1999;60:245-248.
    • (1999) J. Clin. Psychiatry , vol.60 , pp. 245-248
    • Cabras, P.L.1    Hardoy, M.J.2    Hardoy, M.C.3    Carta, M.G.4
  • 138
    • 0033773559 scopus 로고    scopus 로고
    • Adjunctive gabapentin treatment of bipolar disorder
    • Vieta E, Martinez-Aran A, Nieto E, et al. Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry 2000;15:433-437.
    • (2000) Eur. Psychiatry , vol.15 , pp. 433-437
    • Vieta, E.1    Martinez-Aran, A.2    Nieto, E.3
  • 139
    • 0035026069 scopus 로고    scopus 로고
    • Gabapentin treatment of the non-refractory bipolar spectrum: An open case series
    • Ghaemi SN, Goodwin FK. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series. J Affect Disord 2001;65:167-171.
    • (2001) J. Affect. Disord. , vol.65 , pp. 167-171
    • Ghaemi, S.N.1    Goodwin, F.K.2
  • 141
    • 0035089210 scopus 로고    scopus 로고
    • Gabapentin and the prophylaxis of bipolar disorders in patients intolerant to lithium
    • Mauri MC, Laini V, Scalvini ME, et al. Gabapentin and the prophylaxis of bipolar disorders in patients intolerant to lithium. Clin Drug Invest 2001;21:169-174.
    • (2001) Clin. Drug Invest. , vol.21 , pp. 169-174
    • Mauri, M.C.1    Laini, V.2    Scalvini, M.E.3
  • 142
    • 0035206268 scopus 로고    scopus 로고
    • Gabapentin use in geriatric patients with depression and bipolar illness
    • Robillard M, Conn D. Gabapentin use in geriatric patients with depression and bipolar illness. Can J Psychiatry 2001;46:764.
    • (2001) Can. J. Psychiatry , vol.46 , pp. 764
    • Robillard, M.1    Conn, D.2
  • 143
    • 0032789136 scopus 로고    scopus 로고
    • Treatment of social phobia with gabapentin: A placebo-controlled study
    • Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999;19:341-348.
    • (1999) J. Clin. Psychopharmacol. , vol.19 , pp. 341-348
    • Pande, A.C.1    Davidson, J.R.2    Jefferson, J.W.3
  • 144
    • 0033942108 scopus 로고    scopus 로고
    • Placebo-controlled study of gabapentin treatment of panic disorder
    • Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000;20:467-471.
    • (2000) J. Clin. Psychopharmacol. , vol.20 , pp. 467-471
    • Pande, A.C.1    Pollack, M.H.2    Crockatt, J.3
  • 145
    • 0035722908 scopus 로고    scopus 로고
    • Demographics and illness characteristics of the first 261 patients
    • The Stanley Foundation Bipolar Treatment Outcome Network. II
    • Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001;67:45-59.
    • (2001) J. Affect. Disord. , vol.67 , pp. 45-59
    • Suppes, T.1    Leverich, G.S.2    Keck, P.E.3
  • 146
    • 0035096665 scopus 로고    scopus 로고
    • Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder
    • McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158: 420-426.
    • (2001) Am. J. Psychiatry , vol.158 , pp. 420-426
    • McElroy, S.L.1    Altshuler, L.L.2    Suppes, T.3
  • 147
    • 0036176898 scopus 로고    scopus 로고
    • The comorbidity of bipolar and anxiety disorders: Prevalence, psychobiology, and treatment issues
    • Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002;68:1-23.
    • (2002) J. Affect. Disord. , vol.68 , pp. 1-23
    • Freeman, M.P.1    Freeman, S.A.2    McElroy, S.L.3
  • 148
    • 0032848061 scopus 로고    scopus 로고
    • Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
    • White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 1999;40(Suppl 5):S2-S10.
    • (1999) Epilepsia , vol.40 , Issue.SUPPL. 5
    • White, H.S.1
  • 149
    • 0031883542 scopus 로고    scopus 로고
    • A summary of mechanistic hypotheses of gabapentin pharmacology
    • Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29:233-249.
    • (1998) Epilepsy Res. , vol.29 , pp. 233-249
    • Taylor, C.P.1    Gee, N.S.2    Su, T.Z.3
  • 152
    • 0031716650 scopus 로고    scopus 로고
    • Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder
    • Cora-Locatelli G, Greenberg BD, Martin J, Murphy DL. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. J Clin Psychiatry 1998;59:480-481.
    • (1998) J. Clin. Psychiatry , vol.59 , pp. 480-481
    • Cora-Locatelli, G.1    Greenberg, B.D.2    Martin, J.3    Murphy, D.L.4
  • 153
    • 0030898703 scopus 로고    scopus 로고
    • Treatment of restless legs syndrome with gabapentin
    • Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997;20:148-151.
    • (1997) Clin. Neuropharmacol. , vol.20 , pp. 148-151
    • Adler, C.H.1
  • 154
    • 0031859210 scopus 로고    scopus 로고
    • Gabapentin for treatment of pain and tremor: A large case series
    • Merren MD. Gabapentin for treatment of pain and tremor: a large case series. South Med J 1998;91:739-744.
    • (1998) South Med. J. , vol.91 , pp. 739-744
    • Merren, M.D.1
  • 155
    • 0031126348 scopus 로고    scopus 로고
    • A pharmacological and clinical review on topiramate, a new antiepileptic drug
    • Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997;35:241-256.
    • (1997) Pharmacol. Res. , vol.35 , pp. 241-256
    • Perucca, E.1
  • 157
    • 0035040961 scopus 로고    scopus 로고
    • Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: A case-series
    • Roy Chengappa KN, Levine J, Rathore D, Parepally H, Atzert R. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. Eur Psychiatry 2001;16:186-190.
    • (2001) Eur. Psychiatry , vol.16 , pp. 186-190
    • Roy Chengappa, K.N.1    Levine, J.2    Rathore, D.3    Parepally, H.4    Atzert, R.5
  • 158
    • 0033188340 scopus 로고    scopus 로고
    • Topiramate as add-on treatment for patients with bipolar mania
    • Chengappa KN, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42-53.
    • (1999) Bipolar. Disord. , vol.1 , pp. 42-53
    • Chengappa, K.N.1    Rathore, D.2    Levine, J.3
  • 159
    • 0034128353 scopus 로고    scopus 로고
    • Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults
    • Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(Suppl 1):S66-S71.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 1
    • Reife, R.1    Pledger, G.2    Wu, S.C.3
  • 160
    • 0032171131 scopus 로고    scopus 로고
    • Use of topiramate, a new anti-epileptic as a mood stabilizer
    • Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998;50:245-251.
    • (1998) J. Affect. Disord. , vol.50 , pp. 245-251
    • Marcotte, D.1
  • 161
    • 0002452879 scopus 로고    scopus 로고
    • Topiramate augmentation in women with refractory rapid cycling bipolar disorder and significant weight gain from previous treatment
    • Kusumakar V, Yatham LN, O'Donovan C, Kutcher SP. Topiramate augmentation in women with refractory rapid cycling bipolar disorder and significant weight gain from previous treatment. Bipolar Disord 1999;1(Suppl 1):38-39.
    • (1999) Bipolar. Disord. , vol.1 , Issue.SUPPL. 1 , pp. 38-39
    • Kusumakar, V.1    Yatham, L.N.2    O'Donovan, C.3    Kutcher, S.P.4
  • 162
    • 0034128399 scopus 로고    scopus 로고
    • Open-label adjunctive topiramate in the treatment of bipolar disorders
    • McElroy SL, Suppes T, Keck PE, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000;47:1025-1033.
    • (2000) Biol. Psychiatry , vol.47 , pp. 1025-1033
    • McElroy, S.L.1    Suppes, T.2    Keck, P.E.3
  • 163
    • 0033188340 scopus 로고    scopus 로고
    • Topiramate as add-on treatment for patients with bipolar mania
    • Chengappa RKN, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42 53.
    • (1999) Bipolar. Disord. , vol.1 , pp. 42-53
    • Chengappa, R.K.N.1    Rathore, D.2    Levine, J.3
  • 164
    • 0036268105 scopus 로고    scopus 로고
    • Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study
    • McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002;4:207-213.
    • (2002) Bipolar. Disord. , vol.4 , pp. 207-213
    • McIntyre, R.S.1    Mancini, D.A.2    McCann, S.3    Srinivasan, J.4    Sagman, D.5    Kennedy, S.H.6
  • 165
    • 0034894516 scopus 로고    scopus 로고
    • Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design
    • Grunze HC, Normann C, Langosch J, et al. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. J Clin Psychiatry 2001;62:464-468.
    • (2001) J. Clin. Psychiatry , vol.62 , pp. 464-468
    • Grunze, H.C.1    Normann, C.2    Langosch, J.3
  • 166
    • 0034899398 scopus 로고    scopus 로고
    • Topiramate in posttraumatic stress disorder: Preliminary clinical observations
    • Berlant JL. Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry 2001;62(Suppl 17):60-63.
    • (2001) J. Clin. Psychiatry , vol.62 , Issue.SUPPL. 17 , pp. 60-63
    • Berlant, J.L.1
  • 167
    • 0027420928 scopus 로고
    • Postsynaptic factors in the expression of long-term potentiation (LTP): Increased glutamate receptor binding following LTP induction in vivo
    • Maren S, Tocco G, Standley S, Baudry M, Thompson RF. Postsynaptic factors in the expression of long-term potentiation (LTP): increased glutamate receptor binding following LTP induction in vivo. Proc Natl Acad Sci USA 1993;90:9654-9658.
    • (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 9654-9658
    • Maren, S.1    Tocco, G.2    Standley, S.3    Baudry, M.4    Thompson, R.F.5
  • 168
    • 0027941257 scopus 로고
    • Synaptic plasticity in the hippocampus: LTP and LTD
    • Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994;78:535-538.
    • (1994) Cell , vol.78 , pp. 535-538
    • Malenka, R.C.1
  • 169
    • 33947109040 scopus 로고    scopus 로고
    • Psychosocial stressors as predisposing factors to affective illness and PTSD: Potential neurobiological mechanisms and theoretical implications
    • Cicchetti D, Walker E, editors. New York: Cambridge University Press in press
    • Post RM, Leverich GS, Weiss SR, Zhang LX, Li H, Smith M. Psychosocial stressors as predisposing factors to affective illness and PTSD: potential neurobiological mechanisms and theoretical implications. In: Cicchetti D, Walker E, editors. Neurodevelopmental mechanisms in psychopathology, New York: Cambridge University Press, 2001, in press.
    • (2001) Neurodevelopmental Mechanisms in Psychopathology
    • Post, R.M.1    Leverich, G.S.2    Weiss, S.R.3    Zhang, L.X.4    Li, H.5    Smith, M.6
  • 170
    • 0033816145 scopus 로고    scopus 로고
    • A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures
    • Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
    • (2000) Epilepsia , vol.41 , pp. 1167-1178
    • Aldenkamp, A.P.1    Baker, G.2    Mulder, O.G.3
  • 171
    • 0021713537 scopus 로고
    • CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls
    • Gerner RH, Fairbanks L, Anderson GM, et al. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry 1984;141:1533-1540.
    • (1984) Am. J. Psychiatry , vol.141 , pp. 1533-1540
    • Gerner, R.H.1    Fairbanks, L.2    Anderson, G.M.3
  • 173
    • 0032697988 scopus 로고    scopus 로고
    • Tiagabine and the treatment of refractory bipolar disorder
    • Schaffer LC, Schaffer CB. Tiagabine and the treatment of refractory bipolar disorder. Am J Psychiatry 1999;156:2014-2015.
    • (1999) Am. J. Psychiatry , vol.156 , pp. 2014-2015
    • Schaffer, L.C.1    Schaffer, C.B.2
  • 174
    • 0032464043 scopus 로고    scopus 로고
    • Adjunctive tiagabine treatment of psychiatric disorders: Three cases
    • Kaufman KR. Adjunctive tiagabine treatment of psychiatric disorders: three cases. Ann Clin Psychiatry 1998;10:181-184.
    • (1998) Ann. Clin. Psychiatry , vol.10 , pp. 181-184
    • Kaufman, K.R.1
  • 176
    • 0031747791 scopus 로고    scopus 로고
    • Nonconvulsive status epilepticus in two patients receiving tiagabine treatment
    • Eckardt KM, Steinhoff BJ. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998;39:671-674.
    • (1998) Epilepsia , vol.39 , pp. 671-674
    • Eckardt, K.M.1    Steinhoff, B.J.2
  • 177
    • 0033180239 scopus 로고    scopus 로고
    • Tiagabine-induced absence status in idiopathic generalized epilepsy
    • Knake S, Hamer HM, Schomburg U, Oertel WH, Rosenow F. Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 1999;8:314-317.
    • (1999) Seizure , vol.8 , pp. 314-317
    • Knake, S.1    Hamer, H.M.2    Schomburg, U.3    Oertel, W.H.4    Rosenow, F.5
  • 178
    • 0030035708 scopus 로고    scopus 로고
    • Mechanisms of T-type calcium channel blockade by zonisamide
    • Kito M, Maehara M, Watanabe K. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 1996;5:115-119.
    • (1996) Seizure , vol.5 , pp. 115-119
    • Kito, M.1    Maehara, M.2    Watanabe, K.3
  • 180
    • 0028860733 scopus 로고
    • Effects of zonisamide on dopaminergic system
    • Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;22:193-205.
    • (1995) Epilepsy Res. , vol.22 , pp. 193-205
    • Okada, M.1    Kaneko, S.2    Hirano, T.3
  • 182
  • 183
    • 0027938365 scopus 로고
    • The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania
    • Kanba S, Yagi G, Kamijima K, et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:707-715.
    • (1994) Prog. Neuropsychopharmacol. Biol. Psychiatry , vol.18 , pp. 707-715
    • Kanba, S.1    Yagi, G.2    Kamijima, K.3
  • 184
    • 0032563178 scopus 로고    scopus 로고
    • Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
    • Klitgaard H, Matagne A, Gobert J, Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191-206.
    • (1998) Eur. J. Pharmacol. , vol.353 , pp. 191-206
    • Klitgaard, H.1    Matagne, A.2    Gobert, J.3    Wulfert, E.4
  • 185
    • 0034864144 scopus 로고    scopus 로고
    • Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?
    • Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 2001;42(Suppl 4):13-18.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 4 , pp. 13-18
    • Klitgaard, H.1
  • 186
    • 0031908063 scopus 로고    scopus 로고
    • Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
    • Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling
    • (1998) J. Pharmacol. Exp. Ther. , vol.284 , pp. 474-479
    • Loscher, W.1    Honack, D.2    Rundfeldt, C.3
  • 187
    • 0034530035 scopus 로고    scopus 로고
    • Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam
    • Loscher W, Honack D. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam. Epilepsia 2000;41:1499-1506.
    • (2000) Epilepsia , vol.41 , pp. 1499-1506
    • Loscher, W.1    Honack, D.2
  • 188
    • 0030574062 scopus 로고    scopus 로고
    • The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata
    • Loscher W, Honack D, Bloms-Funke P. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata. Brain Res 1996;735:208-216.
    • (1996) Brain Res. , vol.735 , pp. 208-216
    • Loscher, W.1    Honack, D.2    Bloms-Funke, P.3
  • 189
    • 0036193683 scopus 로고    scopus 로고
    • Selective blockade of N-type calcium channels by levetiracetam
    • Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 2002;43:9-18.
    • (2002) Epilepsia , vol.43 , pp. 9-18
    • Lukyanetz, E.A.1    Shkryl, V.M.2    Kostyuk, P.G.3
  • 190
    • 0033811027 scopus 로고    scopus 로고
    • Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures
    • European Levetiracetam Study Group
    • Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 2000;41:1179-1186.
    • (2000) Epilepsia , vol.41 , pp. 1179-1186
    • Shorvon, S.D.1    Lowenthal, A.2    Janz, D.3    Bielen, E.4    Loiseau, P.5
  • 191
    • 0033775210 scopus 로고    scopus 로고
    • Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy
    • European Levetiracetam Study Group
    • Ben Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 2000;41:1276-1283.
    • (2000) Epilepsia , vol.41 , pp. 1276-1283
    • Ben Menachem, E.1    Falter, U.2
  • 192
  • 194
    • 0004118573 scopus 로고
    • A remarkable medicine has been overlooked
    • New York: Simon and Schuster
    • Dreyfus J. A remarkable medicine has been overlooked. New York: Simon and Schuster, 1981.
    • (1981)
    • Dreyfus, J.1
  • 198
    • 0021593902 scopus 로고
    • Selective response to the anticonvulsant carbamazepine in manic-depressive illness: A case study
    • Post RM, Berrettini WH, Uhde TW, Kellner CH. Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study. J Clin Psychopharmacol 1984;4:178-185.
    • (1984) J. Clin. Psychopharmacol. , vol.4 , pp. 178-185
    • Post, R.M.1    Berrettini, W.H.2    Uhde, T.W.3    Kellner, C.H.4
  • 199
    • 0032837029 scopus 로고    scopus 로고
    • The use of primidone in the treatment of refractory bipolar disorder
    • Schaffer LC, Schaffer CB, Caretto J. The use of primidone in the treatment of refractory bipolar disorder. Ann Clin Psychiatry 1999;11:61-66.
    • (1999) Ann. Clin. Psychiatry , vol.11 , pp. 61-66
    • Schaffer, L.C.1    Schaffer, C.B.2    Caretto, J.3
  • 200
    • 0027229938 scopus 로고
    • Barbiturate anticonvulsants in refractory affective disorders
    • Hayes SG. Barbiturate anticonvulsants in refractory affective disorders. Ann Clin Psychiatry 1993;5:35-44.
    • (1993) Ann. Clin. Psychiatry , vol.5 , pp. 35-44
    • Hayes, S.G.1
  • 201
    • 0021670332 scopus 로고
    • Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis
    • Inoue H, Hazama H, Hamazoe K, et al. Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. Folia Psychiatr Neurol Jpn 1984;38:425-436.
    • (1984) Folia Psychiatr. Neurol. Jpn. , vol.38 , pp. 425-436
    • Inoue, H.1    Hazama, H.2    Hamazoe, K.3
  • 203
    • 0025234763 scopus 로고
    • Adjunctive clonazepam for maintenance treatment of bipolar affective disorder
    • Sachs GS, Rosenbaum JF, Jones L. Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. J Clin Psychopharmacol 1990;10:42-47.
    • (1990) J. Clin. Psychopharmacol. , vol.10 , pp. 42-47
    • Sachs, G.S.1    Rosenbaum, J.F.2    Jones, L.3
  • 205
    • 0033984510 scopus 로고    scopus 로고
    • Vagus nerve stimulation: A new tool for brain research and therapy
    • George MS, Sackeim HA, Rush AJ, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 2000;47:287-295.
    • (2000) Biol. Psychiatry , vol.47 , pp. 287-295
    • George, M.S.1    Sackeim, H.A.2    Rush, A.J.3
  • 206
    • 0033961645 scopus 로고    scopus 로고
    • Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
    • Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000;47:276-286.
    • (2000) Biol. Psychiatry , vol.47 , pp. 276-286
    • Rush, A.J.1    George, M.S.2    Sackeim, H.A.3
  • 207
    • 0037084471 scopus 로고    scopus 로고
    • Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes
    • Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002;51:280-287.
    • (2002) Biol. Psychiatry , vol.51 , pp. 280-287
    • Marangell, L.B.1    Rush, A.J.2    George, M.S.3
  • 208
    • 0034784012 scopus 로고    scopus 로고
    • Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome
    • Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001;25:713-728.
    • (2001) Neuropsychopharmacology , vol.25 , pp. 713-728
    • Sackeim, H.A.1    Rush, A.J.2    George, M.S.3
  • 210
    • 0000459326 scopus 로고
    • Clinical studies on nimodipine in the treatment of patients with depressive syndromes in the second half of life
    • Betz E, Deck K, Hoffmeister F, editors. Stuttgart: Schattauer
    • Eckmann F. Clinical studies on nimodipine in the treatment of patients with depressive syndromes in the second half of life. In: Betz E, Deck K, Hoffmeister F, editors. Nimodipine: pharmacological and clinical studies, Stuttgart: Schattauer, 1985. pp. 307-313.
    • (1985) Nimodipine: Pharmacological and Clinical Studies , pp. 307-313
    • Eckmann, F.1
  • 211
    • 0026320723 scopus 로고
    • Disturbi affettivi bipolari e ruolo del calcio intraneuronale. Effetti terapeutici del trattamento con sali di litio e/o calcio antagonista in pazienti con rapida inversione di polarita
    • Manna V. Disturbi affettivi bipolari e ruolo del calcio intraneuronale. Effetti terapeutici del trattamento con sali di litio e/o calcio antagonista in pazienti con rapida inversione di polarita [Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion]. Minerva Med 1991;82:757-763.
    • (1991) Minerva Med. , vol.82 , pp. 757-763
    • Manna, V.1
  • 212
    • 0030050982 scopus 로고    scopus 로고
    • Ultra-rapid and ultradian cycling in bipolar affective illness
    • Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996;168:314-323.
    • (1996) Br. J. Psychiatry , vol.168 , pp. 314-323
    • Kramlinger, K.G.1    Post, R.M.2
  • 213
    • 0025166101 scopus 로고
    • Calcium receptor antagonists modify cocaine effects in the central nervous system differently
    • Pani L, Kuzmin A, Diana M, De Montis G, Gessa GL, Rossetti ZL. Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol 1990;190:217-221.
    • (1990) Eur. J. Pharmacol. , vol.190 , pp. 217-221
    • Pani, L.1    Kuzmin, A.2    Diana, M.3    De Montis, G.4    Gessa, G.L.5    Rossetti, Z.L.6
  • 214
    • 0025145464 scopus 로고
    • Dihydropyridine calcium antagonists prevent cocaine-, but not amphetamine-, induced dopamine release and motor activity in rats
    • Rossetti ZL, Pani L, Kuzmin A, Carboni S, Gessa GL. Dihydropyridine calcium antagonists prevent cocaine-, but not amphetamine-, induced dopamine release and motor activity in rats. Acta Physiol Hung 1990;75:249-250.
    • (1990) Acta Physiol. Hung , vol.75 , pp. 249-250
    • Rossetti, Z.L.1    Pani, L.2    Kuzmin, A.3    Carboni, S.4    Gessa, G.L.5
  • 215
    • 0032509704 scopus 로고    scopus 로고
    • Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model
    • Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998;341:145-152.
    • (1998) Eur. J. Pharmacol. , vol.341 , pp. 145-152
    • Voskuyl, R.A.1    Vreugdenhil, M.2    Kang, J.X.3    Leaf, A.4
  • 217
    • 0036200360 scopus 로고    scopus 로고
    • Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients
    • Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002;43:103-104.
    • (2002) Epilepsia , vol.43 , pp. 103-104
    • Schlanger, S.1    Shinitzky, M.2    Yam, D.3
  • 218
    • 0032909325 scopus 로고    scopus 로고
    • Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial
    • Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-412.
    • (1999) Arch. Gen. Psychiatry , vol.56 , pp. 407-412
    • Stoll, A.L.1    Severus, W.E.2    Freeman, M.P.3
  • 219
    • 0036190807 scopus 로고    scopus 로고
    • Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder
    • Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-479.
    • (2002) Am. J. Psychiatry , vol.159 , pp. 477-479
    • Nemets, B.1    Stahl, Z.2    Belmaker, R.H.3
  • 220
    • 0036790628 scopus 로고    scopus 로고
    • A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
    • Peet M, Horrobin DF. A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59.
    • (2002) Arch. Gen. Psychiatry , pp. 59
    • Peet, M.1    Horrobin, D.F.2
  • 221
    • 0035089629 scopus 로고    scopus 로고
    • Convulsive therapy: A review of the first 55 years
    • Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord 2001;63:1-15.
    • (2001) J. Affect. Disord. , vol.63 , pp. 1-15
    • Fink, M.1
  • 222
    • 0028047366 scopus 로고
    • Electroconvulsive therapy of acute manic episodes: A review of 50 years' experience
    • Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994;151:169-176.
    • (1994) Am. J. Psychiatry , vol.151 , pp. 169-176
    • Mukherjee, S.1    Sackeim, H.A.2    Schnur, D.B.3
  • 223
    • 0028019235 scopus 로고
    • Maintenance ECT in intractable manic-depressive disorders
    • Vanelle JM, Loo H, Galinowski A, et al. Maintenance ECT in intractable manic-depressive disorders. Conv Ther 1994;10:195-205.
    • (1994) Conv. Ther. , vol.10 , pp. 195-205
    • Vanelle, J.M.1    Loo, H.2    Galinowski, A.3
  • 224
    • 0034199344 scopus 로고    scopus 로고
    • Combined ECT and clozapine in treatment-resistant mania
    • Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT 2000;16:204-207.
    • (2000) J. ECT , vol.16 , pp. 204-207
    • Chanpattana, W.1
  • 225
    • 0031805658 scopus 로고    scopus 로고
    • Cost reduction with maintenance ECT in refractory bipolar disorder
    • Bonds C, Frye MA, Coudreaut MF, et al. Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT 1998;14:36-41.
    • (1998) J. ECT , vol.14 , pp. 36-41
    • Bonds, C.1    Frye, M.A.2    Coudreaut, M.F.3
  • 226
    • 0033431865 scopus 로고    scopus 로고
    • Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism
    • Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999;46:1603-1613.
    • (1999) Biol. Psychiatry , vol.46 , pp. 1603-1613
    • Kimbrell, T.A.1    Little, J.T.2    Dunn, R.T.3
  • 227
    • 0034672231 scopus 로고    scopus 로고
    • Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients
    • Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000;48:1133-1141.
    • (2000) Biol. Psychiatry , vol.48 , pp. 1133-1141
    • Speer, A.M.1    Kimbrell, T.A.2    Wassermann, E.M.3
  • 229
    • 0033931360 scopus 로고    scopus 로고
    • Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode
    • Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000;3:129-134.
    • (2000) Int. J. Neuropsychopharmacol. , vol.3 , pp. 129-134
    • Pridmore, S.1    Bruno, R.2    Turnier-Shea, Y.3    Reid, P.4    Rybak, M.5
  • 230
    • 0033964404 scopus 로고    scopus 로고
    • Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study
    • Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000;47:314-324.
    • (2000) Biol. Psychiatry , vol.47 , pp. 314-324
    • Grunhaus, L.1    Dannon, P.N.2    Schreiber, S.3
  • 231
    • 0037090395 scopus 로고    scopus 로고
    • Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: Preliminary results of a randomized trial
    • Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002;51:659-667.
    • (2002) Biol. Psychiatry , vol.51 , pp. 659-667
    • Janicak, P.G.1    Dowd, S.M.2    Martis, B.3
  • 232
    • 0033977080 scopus 로고    scopus 로고
    • The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study
    • Frye MA, Ketter TA, Leverich GS, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000;61:9-15.
    • (2000) J. Clin. Psychiatry , vol.61 , pp. 9-15
    • Frye, M.A.1    Ketter, T.A.2    Leverich, G.S.3
  • 233
    • 0035146920 scopus 로고    scopus 로고
    • The star systems - Overview and use in determining antiepileptic drug choice
    • Brodie MJ, Kwan P. The star systems - overview and use in determining antiepileptic drug choice. CNS Drugs 2001;15:1-12.
    • (2001) CNS Drugs , vol.15 , pp. 1-12
    • Brodie, M.J.1    Kwan, P.2
  • 235
    • 0035826424 scopus 로고    scopus 로고
    • Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder
    • Ftouhi-Paquin N, Alda M, Grof P, Chretien N, Rouleau G, Turecki G. Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder. Am J Med Genet 2001;105:301-305.
    • (2001) Am. J. Med. Genet. , vol.105 , pp. 301-305
    • Ftouhi-Paquin, N.1    Alda, M.2    Grof, P.3    Chretien, N.4    Rouleau, G.5    Turecki, G.6
  • 236
    • 0033810469 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms and the future of genetic epidemiology
    • Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000;58:250-264.
    • (2000) Clin. Genet. , vol.58 , pp. 250-264
    • Schork, N.J.1    Fallin, D.2    Lanchbury, J.S.3
  • 239
    • 0028127340 scopus 로고
    • Seizures in two patients after the addition of lithium to a clozapine regimen
    • [letter]
    • Garcia G, Crismon ML, Dorson PG. Seizures in two patients after the addition of lithium to a clozapine regimen [letter]. J Clin Psychopharmacol 1994;14:426-428.
    • (1994) J. Clin. Psychopharmacol. , vol.14 , pp. 426-428
    • Garcia, G.1    Crismon, M.L.2    Dorson, P.G.3
  • 240
    • 0033595496 scopus 로고    scopus 로고
    • Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
    • Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53:S53-S67.
    • (1999) Neurology , vol.53
    • Ketter, T.A.1    Post, R.M.2    Theodore, W.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.